Who benefits most from Lipitor?
Lipitor (atorvastatin) lowers LDL cholesterol and triglycerides while raising HDL, reducing cardiovascular risks like heart attacks and strokes. Clinical trials show the greatest absolute risk reductions in high-risk patients, where baseline event rates are highest.[1]
Patients with existing heart disease
People with a history of heart attack, stroke, or stable coronary artery disease see the largest benefits. The TNT trial found atorvastatin 80 mg cut major cardiovascular events by 22% versus 10 mg in these patients, with number needed to treat (NNT) as low as 25 over 5 years.[2]
High-risk primary prevention cases
Individuals without prior events but with multiple risk factors—such as diabetes, hypertension, smoking, or LDL over 190 mg/dL—gain substantial protection. The ASCOT-LLA trial showed a 36% relative risk reduction in nonfatal heart attacks for hypertensive patients with average cholesterol.[3]
Diabetics at elevated cardiovascular risk
Type 2 diabetics over 40 with one risk factor (e.g., hypertension) benefit significantly. CARDS trial data indicate atorvastatin 10 mg reduced major events by 37%, with NNT of 95 over 4 years.[4]
Why not everyone?
Low-risk patients (under 10% 10-year event risk) see minimal absolute benefit; statins like Lipitor add little beyond lifestyle changes, per USPSTF guidelines recommending against routine use.[5] Benefits scale with risk level.
[1] Lipitor prescribing information, Pfizer
[2] TNT trial, NEJM 2005
[3] ASCOT-LLA, Lancet 2003
[4] CARDS trial, Lancet 2004
[5] USPSTF statin recommendations, JAMA 2022